Position in ALLO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$862,137
+$51,164 QoQ
Shares Held
353,335
-40.3% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Derivatives in ALLO
reported options exposure · as of Sep 30, 2022CallValue
$324,000
CallShares
30,000
PutValue
$324,000
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,808,560 across 402 Biotechnology names. ALLO ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in ALLO
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $862,137 | 353,335 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $810,973 | 591,952 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $736,682 | 594,099 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $726,071 | 642,542 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,005,243 | 688,524 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,525,581 | 716,236 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,314,067 | 469,310 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $175,150 | 75,172 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,031,683 | 678,229 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $110,179 | 34,324 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,073,854 | 338,756 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,398,378 | 281,364 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,743,394 | 555,343 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,166,093 | 344,371 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,944,121 | 457,789 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $324,000 | 30,000 | Put | Defined | 2022-11-10 | |
| 2022-09-30 | $324,000 | 30,000 | Call | Defined | 2022-11-10 | |
| 2022-06-30 | $2,747,001 | 240,965 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,085,593 | 119,165 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $3,959,528 | 265,384 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $3,255,033 | 126,655 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $5,171,351 | 198,288 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,375,823 | 123,961 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $569,692 | 22,571 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $405,947 | 10,765 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,135,432 | 49,870 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $886,775 | 45,616 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||